Tag: HAL

Finance

Top Wall Street Stories : Brooks Automation (NASDAQ:BRKS), Fidelity National Information (NYSE:FIS), Halliburton (NYSE:HAL), Abercrombie & Fitch Co. (NYSE:ANF), Adobe (NASDAQ:ADBE)

Brooks Automation Inc. (NASDAQ:BRKS) Insider David Pietrantoni unloaded 2,500 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $11.07, for a total transaction of $27,675.00. Following the transaction, the insider now directly owns 78,486 shares of the company’s stock, valued at approximately $868,840. Brooks Automation, Inc. (NASDAQ:BRKS) belongs to Technology sector. … Continue reading Top Wall Street Stories : Brooks Automation (NASDAQ:BRKS), Fidelity National Information (NYSE:FIS), Halliburton (NYSE:HAL), Abercrombie & Fitch Co. (NYSE:ANF), Adobe (NASDAQ:ADBE)

Mark DeFrance
Finance

Investors Are Watching : Halliburton Company (NYSE:HAL), Insmed (NASDAQ:INSM), FactSet Research Systems (NYSE:FDS), Keurig Green Mountain, Inc. (NASDAQ:GMCR), Great Panther (NYSEMKT:GPL)

Halliburton Company (NYSE:HAL)‘s stock had its “neutral” rating reaffirmed by Zacks in a note issued to investors on Friday. They currently have a $71.00 target price on the stock. Zacks‘s target price indicates a potential upside of 5.01% from the stock’s previous close. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 9.50% and weekly performance is 0.21%. On last trading … Continue reading Investors Are Watching : Halliburton Company (NYSE:HAL), Insmed (NASDAQ:INSM), FactSet Research Systems (NYSE:FDS), Keurig Green Mountain, Inc. (NASDAQ:GMCR), Great Panther (NYSEMKT:GPL)

Colin Pettis
Finance

Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

On 4 AUG Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that the company will host its Second Quarter 2014 Investor Conference Call on Monday, August 11. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) belongs to Healthcare sector. Its weekly performance is 12.98%. On last trading day company shares ended up $6.53. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving average (SMA50) is -5.40%. On 31 JULY Acorda Therapeutics, Inc. … Continue reading Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

Kevin Long